Deliver Your News to the World

Royal DSM and Lallemand conclude license agreement


Royal DSM and Lallemand Inc. are pleased to announce a joint agreement under which DSM grants to Lallemand a non-exclusive, royalty bearing license to DSMís low-glycerol yeast technology patents (U.S. Patent No. 8,795,998).† The license agreement is part of a settlement that was reached following a 2018 US Federal Court jury verdict in Wisconsin.† The referenced technology in the agreement is for use in the fermentation of first-generation biofuels. †


Lallemand is a privately owned company specializing in the research, development, production, marketing and distribution of yeast, bacteria and other microorganisms for use in the food ingredient, human nutrition, animal nutrition, baking, wine, beer, distilled spirits, biofuels, plant care, cosmetic and pharmaceutical industries. Lallemand has approximately 4,000 employees located in more than 40 countries, on all continents. More information can be found at†

( Press Release Image: )


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.